GENX Generix Group SA

Generix Group - Q1 2022/2023 REVENUES: €20.9M New SaaS contracts Q1 2022/2023: €1.2m Growth in SaaS revenues: 11%

Generix Group - Q1 2022/2023 REVENUES: €20.9M New SaaS contracts Q1 2022/2023: €1.2m Growth in SaaS revenues: 11%

PRESS RELEASE

Paris, July 26, 2022

Q1 2022/2023 REVENUES: €20.9M

New SaaS contracts Q1 2022/2023: €1.2m

Growth in SaaS revenues: 11%

Generix Group, Industrial, Logistics and Retail Ecosystems provider with leading Collaborative SaaS Solutions, publishes today its revenues for the 2022/2023 first quarter.

Q1 revenues:20.9 million

 Quarter ended

June 30
Change
Unaudited (K€)20222021
SaaS9 0938 18611%
Maintenance4 6374 6460%
Licenses6301 177-46%
Software revenues14 36014 0092,5%
Consulting Services6 5687 234-9%
Revenues20 92821 243-1,5%

Revenues for the quarter amounted to €20.9 million, down 1.5% compared with the first quarter of the previous year.

Thanks to the good signing dynamics of the previous year, SaaS activity grew by 11% during the quarter. This strong growth was recorded in almost all the countries where Generix Group operates, and particularly internationally.

The slowdown in the Licenses activity observed in the second half of the previous fiscal year continued in North America, resulting in a slowdown in Consulting Services activity in this zone. In the other countries, Consulting Services activity grew by an average of 5% compared with the same period last year.

Q1 new SaaS contracts: 1.2 M

 Quarter ended

June 30
Change
Unaudited (K€)20222021
New SaaS contract signing (ACV*)1 2151 664-27,0%

* New signatures expressed in ACV (Annual Contract Value) highlighting the average annual additional revenue that will be generated after deployment of the contracts concerned.

The volume of SaaS signatures for the first quarter of the year was €1.2 million.

As a reminder, the previous year had recorded a record level of signatures for a 1st quarter with a significant restart of activity after the health crisis.

Among these new signatures:

  • in France, a signature with a distribution group wishing to accelerate its digital transformation by equipping itself with Generix Group's EDI and Invoice Services solutions in SaaS mode. This contract completes a first SaaS migration with Generix Group's TMS solution in 2021.



  • in Spain, the adoption of the Generix WMS solution and Data Power for data analysis by a company specialized in the food industry.



Forecast

As indicated at the time of the presentation of the 2021/2022 results, the current financial year is subject to contrasting factors:

  • activity in Russia, currently stable but subject to changes in the international context
  • inflation and its impact on the increase in the wage bill
  • the expected recovery in North America after the low point in the second half of 2021-2022
  • the dynamic of SaaS signatures in the wake of the 2021/2022 rebound, and
  • continued R&D investment to support the competitiveness and performance of the Group's solutions.



On this basis, Generix Group confirms that it anticipates stronger growth in 2022/2023 than in 2021/2022, but stable EBITDA.

Supplemental and non-IFRS Financial Information

Supplemental non-IFRS information (above-mentioned as EBITDA) presented in this press release is subject to inherent limitations. It is not based on any comprehensive set of accounting rules or principles and should not be considered as a substitute for IFRS measurements. Also, the Company’s supplemental non-IFRS financial information may not be comparable to similarly titled non-IFRS measures used by other companies.

Next financial press release: October 25th, 2022, after market closes

Publication of second quarter sales for fiscal year 2022/2023

About Generix Group

Generix Group is a Collaborative Supply Chain expert present in 60 countries, thanks to its subsidiaries and network of partners. More than 6,000 companies around the world use its SaaS solutions. The group’s 800 employees provide daily support for such customers as Carrefour, Danone, FM Logistic, Fnac-Darty, Essilor and Ferrero in the digital transformation of their Supply Chain.

Its collaborative platform, Generix Supply Chain Hub, helps companies to keep the promises they make to their customers. It combines the capabilities to execute physical flows, digitalize information flows, manage collaborative processes and connect companies to all their partners, in real time.

Generix Supply Chain Hub is aimed at all players in the Supply Chain: manufacturers, third- and fourth-party logistics providers (3PL/4PL) and retailers.

Founded in France in 1990, the company is listed on the Eurolist market of Euronext Paris, compartment B (ISIN: FR0010501692). To learn more:

Attachment



EN
26/07/2022

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Generix Group SA

 PRESS RELEASE

Generix Group : Aïda Collette-Sène nommée Présidente du directoire de ...

Generix Group : Aïda Collette-Sène nommée Présidente du directoire de Generix Group                Communiqué de presse      Le 15 septembre 2022 Aïda Collette-Sène nommée Présidente du directoire de Generix Group Generix Group annonce que le Conseil de Surveillance a nommé Madame Aïda Collette-Sène aux fonctions de Présidente du Directoire, à compter du 1er septembre 2022. Directrice Générale de Generix Group depuis avril 2018, après un parcours de près de 20 ans au sein du groupe CGI, elle prend la succession de Monsieur Jean-Charles Deconninck qui dirigeait la société depui...

 PRESS RELEASE

Generix Group - Information relative au nombre total de droits de vote...

Generix Group - Information relative au nombre total de droits de vote et d’actions au 31 août 2022 COMMUNIQUE FINANCIER Lesquin, le 9 Septembre 2022 Generix Group - Information relative au nombre total de droits de vote et d’actions Prévue par l’article L. 233-8 II du Code de Commerce et l’article 223-16 du règlement général de l’Autorité des Marchés Financiers DateNombre d’actionsNombre de droits de vote théoriques des actions31/08/202222 703 86323 198 086 FR À propos de Generix Group  Generix Group est un expert de la Supply Chain Collaborative présent dans plus de 60 pays, grâce à...

 PRESS RELEASE

Résultat de l’Offre Publique d’Achat Simplifiée

Résultat de l’Offre Publique d’Achat Simplifiée Generix Group          Communiqué de presse          Le 25 août 2022 Résultat de l’Offre Publique d’Achat Simplifiée Generix Group et New Gen Holding annoncent que le 24 août 2022, l’Autorité des marchés financiers a publié les résultats de l’offre publique d’achat simplifiée clôturée le 19 août 2022 et visant la totalité des actions Generix Group non détenues par New Gen Holding. A l’issue de l’offre publique d’achat simplifiée, l’Initiateur New Gen Holding a acquis 6 589 041 actions dans le cadre de la procédure de semi-centralisation. ...

 PRESS RELEASE

Generix Group - Information relative au nombre total de droits de vote...

Generix Group - Information relative au nombre total de droits de vote et d’actions au 31 juillet 2022 COMMUNIQUE FINANCIER Lesquin, le 8 Août 2022 Generix Group - Information relative au nombre total de droits de vote et d’actions Prévue par l’article L. 233-8 II du Code de Commerce et l’article 223-16 du règlement général de l’Autorité des Marchés Financiers DateNombre d’actionsNombre de droits de vote théoriques des actions31/07/202222 703 86323 756 862 FR À propos de Generix Group  Generix Group est un expert de la Supply Chain Collaborative présent dans plus de 60 pays, grâce à s...

 PRESS RELEASE

Generix Group - Bilan semestriel du contrat de liquidité GENERIX contr...

Generix Group - Bilan semestriel du contrat de liquidité GENERIX contracté avec NATIXIS ODDO BHF COMMUNIQUE FINANCIER Lesquin, le 3 Aout 2022 Generix Group - Bilan semestriel du contrat de liquidité GENERIX contracté avec NATIXIS ODDO BHF Au titre du contrat de liquidité confié à NATIXIS ODDO BHF portant sur les actions de la société GENERIX, à la date du 30 Juin 2022, les moyens suivants figuraient au compte de liquidité : 27 099 titres GENERIX50 430.95€         Lors du dernier bilan semestriel, à la date du 31 Décembre 2021, les moyens suivants figuraient au compte de liquidité :   ...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch